Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression.
Mendes Sdos S, Candi A, Vansteenbrugge M, Pignon MR, Bult H, Boudjeltia KZ, Munaut C, Raes M. Mendes Sdos S, et al. Among authors: candi a. Cell Signal. 2009 Jul;21(7):1109-22. doi: 10.1016/j.cellsig.2009.02.025. Epub 2009 Mar 12. Cell Signal. 2009. PMID: 19285553 Free article.
Development and validation of a high-throughput screening pipeline of compound libraries to target EMT.
Jonckheere S, Taminau J, Adams J, Haerinck J, De Coninck J, Verstappe J, De Clercq K, Peeters E, Gheldof A, De Smedt E, Goossens V, Audenaert D, Candi A, Versele M, De Groote D, Verschuere H, Stemmler M, Brabletz T, Vandenabeele P, Casali A, Campbell K, Goossens S, Berx G. Jonckheere S, et al. Among authors: candi a. Cell Death Differ. 2025 May 8. doi: 10.1038/s41418-025-01515-6. Online ahead of print. Cell Death Differ. 2025. PMID: 40341726
A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.
Hillen H, Candi A, Vanderhoydonck B, Kowalczyk W, Sansores-Garcia L, Kesikiadou EC, Van Huffel L, Spiessens L, Nijs M, Soons E, Haeck W, Klaassen H, Smets W, Spieser SA, Marchand A, Chaltin P, Ciesielski F, Debaene F, Chen L, Kamal A, Gwaltney SL, Versele M, Halder GA. Hillen H, et al. Among authors: candi a. Mol Cancer Ther. 2024 Jan 3;23(1):3-13. doi: 10.1158/1535-7163.MCT-22-0681. Mol Cancer Ther. 2024. PMID: 37748190
12 results